Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications ; volume:24 ; number:6 ; day:13 ; month:8 ; year:2024 ; pages:729-741 ; date:11.2024
American journal of cardiovascular drugs ; 24, Heft 6 (13.8.2024), 729-741, 11.2024
- Creator
-
Bertolet, Barry D.
Cabral, Katherine P.
Sullenberger, Lance
McAlister, Jan L.
Sandroni, Todd
Patel, Dharmesh S.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40256-024-00665-1
- URN
-
urn:nbn:de:101:1-2501192108068.960757088834
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bertolet, Barry D.
- Cabral, Katherine P.
- Sullenberger, Lance
- McAlister, Jan L.
- Sandroni, Todd
- Patel, Dharmesh S.
- SpringerLink (Online service)
Other Objects (12)
Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Real-World Effectiveness of Lipid-Lowering Medications on Outcomes after Stroke: Potential Implications of the New-User Design
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Nicotinic acid: a lipid-lowering agent with unrealized potential
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
An investigation of the effects of lipid-lowering medications: genome-wide linkage analysis of lipids in the HyperGEN study
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Real-World Effectiveness of Lipid-Lowering Medications on Outcomes after Stroke: Potential Implications of the New-User Design
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Nicotinic acid: a lipid-lowering agent with unrealized potential
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
An investigation of the effects of lipid-lowering medications: genome-wide linkage analysis of lipids in the HyperGEN study
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Real-World Effectiveness of Lipid-Lowering Medications on Outcomes after Stroke: Potential Implications of the New-User Design
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Nicotinic acid: a lipid-lowering agent with unrealized potential
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
An investigation of the effects of lipid-lowering medications: genome-wide linkage analysis of lipids in the HyperGEN study
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation